Veradermics Q2 EPS Beats Estimate
Veradermics reports Q2 EPS of $(0.58), beating the $(0.65) estimate
Veradermics (NYSE: MANE ) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.65) by 10.77 percent.
This is a 97.6 percent increase over losses of $(24.19) per share from the same period last year.